Home
Search

Amicus Briefs

BIO submits amicus briefs on a variety of topics because of the strong interest and relevance to the biotechnology industry.

Featured Amicus Briefs
BIO Files Amicus Brief in Continuing Effort to…
BIO filed an amicus brief in a continuing effort to challenge courts' decisions that undermine FDA authority and hinder patient access to medications.The brief was filed in the Supreme Court of the United States (SCOTUS), following the August 2023…
Learn more
BIO Files Amicus Brief Supporting Reversal of…
BIO filed an amicus brief in the U.S. Court of Appeals for the Sixth Circuit, seeking the reversal of a lower court's ruling that would set aside the 2022 rescission of the Securities and Exchange Commission (SEC) 2020 Rule regulating proxy advisory…
Learn more
BIO Files Amicus Brief Urging Harmonization of…
BIO filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit on an important and recurring question concerning the framework for determining patent obviousness in patent litigation. BIO argues that courts, when considering whether…
Learn more
All Amicus Briefs
  • Show All
Search
Results
BIO and Croplife International Submit Amicus Brief in Impression Products Inc. v. Lexmark International Inc. (U.S. Supreme Court)
February 23, 2017
BIO and Croplife International Submit Brief of Amicus Curiae in Impression Products Inc. v. Lexmark International Inc. (Supreme Court of the United States)
BIO and PhRMA Submit Amicus Brief In Re: Verinata Health Inc., Illumina, Inc. (U.S. Court of Appeals for the Federal Circuit)
February 9, 2017
BIO and PhRMA Submit Brief of Amicus Curiae In Re: Verinata Health Inc., Illumina, Inc. 
BIO submits amicus brief In Re Aqua Products, Inc. (U.S. Court of Appeals for the Federal Circuit)
October 25, 2016
The Biotechnology Innovation Organization submitted a brief of amicus curiae supporting the appellant in the case In Re: Aqua Product, Inc. in the United States Court of Appeals for the Federal Circuit
BIO Amicus Brief in The Medicines Company v. Hospira, Inc. (U.S. Court of Appeals)
March 3, 2016
Modern pharmaceutical and biotechnology products typically require lengthy, costly, and resource-intensive development periods before they reach the marketplace. BIO members devote many years and millions of dollars in direct …
BIO and AUTM Amicus Brief in Cuozzo Speed Technologies LLC v. Michelle Lee
March 2, 2016
The questions presented in this case implicate two of the foundational legal conclusions that have allowed the PTAB, even in a relatively short time, to cut a remarkable swath through the ranks of issued patents with barely a…
BIO as Amicus Curiae supporting en banc reconsideration in Prolitec, Inc. v. ScentAir Technologies, Inc. (US Court of Appeals for the Federal Circuit)
February 16, 2016
BIO as Amicus Curiae supporting en banc reconsideration in Prolitec, Inc. v. ScentAir Technologies, Inc. (US Court of Appeals for the Federal Circuit)   STATEMENT OF INTEREST OF AMICUS CURIAE The Biotechnology Innovation Organization (&ldquo…
Brief of Amicus Curiae Biotechnology Innovation Organization in Support of Plaintiffs-Appellees in Amgen Inc. v. Apotex Inc. (U.S. Court of Appeals for the Federal Circuit)
February 16, 2016
Brief of Amicus Curiae Biotechnology Innovation Organization in Support of Plaintiffs-Appellees in Amgen Inc. v. Apotex Inc. (U.S. Court of Appeals for the Federal Circuit) INTEREST OF AMICUS CURIAE   The Biotechnology Innovation Organization (…